Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
SEC-verified vehicles of the same sponsor, predating these roles and carrying none of them. The badge counts them; the figure beside this one does not.
Mergers closed across all 2 — these vehicles and the franchise's earlier ones together.
Announced but not closed, and still hunting — again over all 2.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Ming (K.M.) Chan, also known as Kai Ming Chan, serves as Chief Financial Officer of Archimedes Tech SPAC Partners III Co. (NASDAQ: ARCIU), a blank check company incorporated in 2025 and headquartered in Claymont, Delaware. She was appointed to the CFO role in December 2025, ahead of the SPAC's upsized $240 million IPO, which priced on January 23, 2026, and began trading on the Nasdaq under the symbol "ARCIU." The offering was supported by Walkers as legal advisor, with BTIG acting as sole book-running manager, Loeb & Loeb as issuer's counsel, White & Case as underwriter's counsel, and WithumSmith+Brown as auditor. Archimedes Tech SPAC Partners III is focused on identifying a business combination target in the technology sector, with particular emphasis on artificial intelligence, cloud services, and automotive technology. The management team is led by Chairman Dr. Eric R. Ball, Chief Executive Officer and Director Long Long, Chief Financial Officer Ming (K.M.) Chan, and Chief Technology Officer Ben Landen, with independent director nominees Daniel L. Sheehan and Vishwesh Pai rounding out the board.
In addition to her role at Archimedes III, Ms. Chan concurrently serves as Head of Finance and Operations of Archimedes Tech SPAC Partners II (Archimedes II), indicating a continuing leadership position across the Archimedes SPAC platform. Her LinkedIn profile also references a prior role as Founder & Director, though specific details about that venture are not disclosed in the available sources. Ms. Chan was born in 1977 and received her education at York University, as confirmed by Bloomberg and her professional profiles. The company's registered address is 2093 Philadelphia Pike, #1968, Claymont, Delaware 19703, with a contact number of (725) 312-2430. While the available sources confirm her financial leadership roles within the Archimedes SPAC franchise and her educational background, detailed information regarding her broader career history prior to joining the Archimedes platform, specific prior employers, or additional board seats is limited in the public record. Her track record to date is anchored by her involvement in guiding the Archimedes SPAC series through their capital formation and IPO processes, with Archimedes III's successful upsized offering representing the most notable transaction under her financial oversight.
This record is keyed to SEC CIK 0002105517 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 1 institutional-holder rows on these vehicles, under 1 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.